home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Important Step in Molecular Pathway of Granule Release by Granulocytes Elucidated

 
  September, 1 2000 2:37
your information resource in human molecular genetics
 
     
Arrestin’ regurgitating infection fighters

Nature Immunology, pages 227-233.

The first line of defense against invasion by infectious organisms is the involvement of white blood cells such as neutrophils, basophils and eosinophils, also known as granulocytes. These cells are attracted to sites of infection by chemicals known as chemoattractants and, once there, are able to start fighting the infection.

Granulocytes attack invaders by releasing the contents of granules that they carry. These granules contain a cocktail of molecules that are toxic to many invading organisms. The molecular pathway leading to granule release is a complicated and incompletely understood process.

In the September issue of [Nature Immunology, Vol. 1, No. 3, September 2000], Canadian researchers from the John P. Robarts Research Institute in London, Ontario, have elucidated an important step in the mechanism of this process. They showed that granulocytes receive a signal through their surface receptor, CXCR1, which mobilizes a molecule called b-arrestin to form important signaling complexes. These complexes move to the granules in the cell where they cause release of the toxic granule contents outside the cell.

This work is surprising to many scientists as b-arrestin was previously thought to be involved in a very different cellular process. This study furthers our understanding of the critical role granulocytes play in fighting foreign invaders and adds new dimensions to the role of b-arrestin in normal physiology.

Contact Information:

David J. Kelvin
John P. Robarts Research Institute
Laboratory of Molecular Immunology and Inflammation
1400 Western Road
London, CANADA, ON N6G 2V4
Tel: 519-663-2917
Fax: 519-663-3847
E-mail: kelvin@rri.on.ca

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.